title: Hypertension in 2016: Blood pressure goals, variability and SGLT2 blockade in CKD.
authors.affiliation: Renal, Electrolyte and Hypertension Division, Perelman School of Medicine at the University of Pennsylvania, 1 Founders Building, 3400 Spruce Street, Philadelphia 19104, USA.
authors.forename: Debbie L
authors.initials: DL
authors.lastname: Cohen
authors.affiliation: Renal, Electrolyte and Hypertension Division, Perelman School of Medicine at the University of Pennsylvania, 1 Founders Building, 3400 Spruce Street, Philadelphia 19104, USA.
authors.forename: Raymond R
authors.initials: RR
authors.lastname: Townsend
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001795:Blood Pressure Determination; D018450:Disease Progression; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D010347:Patient Care Planning; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D000077203:Sodium-Glucose Transporter 2 Inhibitors / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D000077203:Sodium-Glucose Transporter 2 Inhibitors